Posted on July 28th, 2014
Dr. Wilcox has been Chairman and CEO of Cocrystal since January 2, 2014.
Company OverviewCocrystal Pharma, Inc. (OTCBB: COCP) was founded to develop and commercialize novel antiviral drugs targeting replication enzymes. To uniquely position the company for success, an executive team with expertise in scientific discovery and commercial pharmaceutical development was assembled. The team includes Chief Scientific Officer Roger Kornberg, winner of the 2006 Nobel Prize for Chemistry for his work with replication enzymes and Chief Executive Officer Gary Wilcox, former Executive Vice President, Operations and Board Member of ICOS Corporation. Dr. Wilcox played a key leadership role in the development and approval of Cialis™, which now has annual sales over $2 billion. CPI uses novel technologies and approaches to create first- and best-in-class antivirals. We believe broad-spectrum antivirals can be developed which will transform both the treatment and prophylaxis of viral diseases. ... Learn More »
July 28 is the 7th World Hepatitis Day, sponsored by the World Hepatitis Alliance in partnership with the World Health ...Read More »
Posted on July 17th, 2014
We have just completed what was an extremely successful Alzheimer’s Association International Conference in Copenhagen...Read More »
Posted on July 9th, 2014
Over the last 24 hours I have received several emails and inquiries from investors as it relates to understanding exactl...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
We are an exclusive, online media publication where public and privatively held firms alike share insights about their companies and industries...Learn More »